About ASTRO
Founded in 1958, ASTRO’s mission is to advance the practice of radiation oncology by promoting excellence in patient care, providing opportunities for educational and professional development, promoting research and disseminating research results and representing radiation oncology in a rapidly evolving health care environment.
ASTRO is the premier radiation oncology society in the world, with more than 10,000 members who are physicians, nurses, biologists, physicists, radiation therapists, dosimetrists and other health care professionals who specialize in treating patients with radiation therapies. These medical professionals, found at hospitals, cancer treatment centers and academic research facilities around the globe, make up the radiation therapy treatment teams that are critical in the fight against cancer. Together, these teams treat more than one million cancer patients each year. As the leading organization in radiation oncology, the Society is dedicated to improving patient care through professional education and training, support for clinical practice and health policy standards, advancement of science and research and advocacy.
ASTRO Membership
The individual applicant must be a current and active ASTRO member, or have submitted an application for ASTRO membership, as of the due date of the fellowship application. If selected, the fellow will be required to maintain their ASTRO membership throughout the duration of the fellowship.
Degree Requirements
The individual applicant must hold a medical degree such as M.D./Ph.D., M.D., D.O., or other equivalent degree(s) as of the due date of the fellowship application. Strong clinical experience, including clinical research experience are highly desired.
Residency Program, Other Trainee Status, and Institutional Affiliation
An eligible applicant must be enrolled in an accredited radiation oncology residency program at an academic, medical or research institution within the United States, and have accumulated at least two years of clinical training by the start of the Fellowship term. Alternatively, the individual applicant can also be someone who previously graduated from a radiation oncology residency program, yet currently maintains a trainee status (such as a postdoctoral training appointment or an advanced degree program) under an U.S. domestic Institution during this ASTRO-AstraZeneca Radiation Oncology Research Training Fellowship. The individual applicant must be able to secure sufficient time (1 year) for the fellowship at AstraZeneca starting July 1, 2024. Faculty members or equivalent status are not eligible to apply.
The Institution must be a U.S. domestic organization, defined as “a public (including a State or other governmental agency) or private non-profit or for-profit organization that is located in the U.S. or its territories, and, is subject to U.S. laws, and assumes legal and financial accountability for awarded funds and for the performance of the fellowship-supported activities.” Once designated in mutual agreement with the applicant, the Institution is legally responsible for providing financial and progress reports as required by ASTRO, and financially responsible for the use and disposition of any funds awarded based on the application.
Eligible Countries:
Sponsor Institute/Organizations: American Society for Radiation Oncology(ASTRO)
Sponsor Type:
Address: 251 18th Street South; 8th Floor; Arlington; VA 22202;United States
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
NA
Varies
Affiliation: American Society for Radiation Oncology(ASTRO)
Address: 251 18th Street South; 8th Floor; Arlington; VA 22202;United States
Website URL: https://www.astro.org/Patient-Care-and-Research/Research/Funding-Opportunities/Frequently-Asked-Questions
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.